VerifiedBiotechnology Research· Founded 2016

Modalis Therapeutics

Modalis Therapeutics Corporation (Tokyo Mothers 4883) is developing precision genetic medicines through epigenetic gene modulation. Modalis is advancing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology which enables the locus specific modulation of gene expression or histone modification without the need for double- stranded DNA cleavage, gene editing or base editing. Modalis is headquartered in Tokyo with laboratories and R&D facilities in Cambridge,

7-day free trial · no credit card

Cambridge, United States21(11 to 50)$1M to <$10M2016modalistx.com LinkedIn

Verified contacts

25

available on Kipplo

LinkedIn employees

21

11 to 50 range

Open roles

—

no listings

Distinct roles

18

indexed titles

Tech stack

0

tools in use

Monthly traffic

184

organic / mo

Sign up free to see all 25 verified contacts at Modalis Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

25 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 25 verified contacts

Top roles at Modalis Therapeutics

18 distinct titles indexed · top 10 shown.

2associate director
2principal scientist
2research associate
2senior research associate
1()
1business development advisor
1co-founder, president, and ceo
1contract recruiter
1director - in vivo pharmacology
1director business development site controller
+8more titles

Sign up to unlock all 25 contacts at Modalis Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 25 verified contacts at Modalis Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Modalis Therapeutics | Kipplo Discover